Adalimumab and etanercept serum (anti)drug levels are not predictive for successful dose reduction or discontinuation in rheumatoid arthritis

Ann Rheum Dis. 2015 Dec;74(12):2260-1. doi: 10.1136/annrheumdis-2015-207814. Epub 2015 Sep 4.

¹ Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands.
² ClinTRID, Karolinska Institute, Stockholm, Sweden.
³ Department of Rheumatology & Clinical Immunology, Utrecht University Medical Centre, Utrecht, The Netherlands.
⁴ Department of Rheumatology, Sint Maartenskliniek, Nijmegen, The Netherlands Department of Rheumatology, Radboud University Medical Centre, Nijmegen, The Netherlands.
⁵ Department of Pharmacy, Sint Maartenskliniek, Nijmegen, The Netherlands Department of Pharmacy, Radboud University Medical Center, Nijmegen, The Netherlands.

No abstract available

Keywords: Anti-TNF; Epidemiology; Rheumatoid Arthritis.

Publication types